-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
LENZ Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q2 2025.
- LENZ Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 28.1M shares, a 9.65% increase year-over-year.
- LENZ Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 21.3M shares, a 986% increase from 2023.
- LENZ Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.96M shares, a 96.4% decline from 2022.
- LENZ Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 54.9M shares, a 89.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)